ClinicalTrials.gov ID: NCT05301140
Ages Eligible: 22 Years and Older
Sexes Eligible: All
Study Phase: Observational [Patient Registry]
Study Completion (Estimated): 2028-12/31
Principal Investigator: Sheila Smith, MD
Contact Information:
EvergreenHealth Research Department
425-899-5385
EvergreenResearch@evergreenhealthcare.org
Summary:
The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout the therapy process. Physicians or sites will receive appropriate remuneration for the effort and cost involved in collecting and transmitting this data to MicroTransponder Inc.
Eligibility Criteria:
Inclusion Criteria
- Patients implanted with the Vivistim System for upper limb deficits associated with an ischemic stroke
Exclusion Criteria
